Mancini Anthony, Chief Global Commercialization Officer exercised 3,121 shares of Revolution Medicines, Inc. ($RVMD) @ $33.62 ($104,928.02 total) on Sep 25, 2026

Mancini Anthony – Chief Global Commercialization Officer

Sep 25, 2026

52W Low$45.60

Current$205.8989.7% above low, 10.3% below high

Purchase$33.62-6.7% above low, 106.7% below high

52W High$224.31

3,121

Price

$33.62

Total Value

$104,928.02

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Mancini Anthony
Title	Chief Global Commercialization Officer
Transaction Date	Sep 25, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Acquired
Security	Common Stock
Direct/Indirect	Direct
Filing Date	Sep 28, 2026
Shares Purchased	3,121
Price per Share	$33.62
Total Value	$104,928.02
Shares Owned After	42,886
Derivative	No
Accession Number	0002124509-26-000012
Document	View SEC Filing